Senti Biosciences, Inc. announced that on April 23, 2024, Deborah Knobelman, Ph.D., the Chief Financial Officer, notified the Company of her decision to resign from her employment with the Company, effective May 3, 2024. Dr. Knobelman?s resignation was not as a result of any disagreements between Dr. Knobelman and the Company on any matter related to the operations, policies, or practices of the Company.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.3689 USD | -0.30% | -0.30% | -44.11% |
1st Jan change | Capi. | |
---|---|---|
-44.11% | 16.88M | |
+3.91% | 109B | |
+10.87% | 105B | |
+1.28% | 22.25B | |
-13.14% | 22.09B | |
-7.05% | 18.68B | |
-38.36% | 17.58B | |
-10.66% | 16.85B | |
+3.75% | 13.76B | |
+36.70% | 12.46B |
- Stock Market
- Equities
- SNTI Stock
- News Senti Biosciences, Inc.
- Senti Biosciences, Inc. Announces Resignation of Deborah Knobelman as Chief Financial Officer, Effective May 3, 2024